Top News
Latest News
INVESTMENT
15 Dec 2025
A $70M Bet on Longer-Lasting Metabolic DrugsINNOVATION
12 Dec 2025
FDA Qualifies AI Tool to Support MASH Clinical TrialsMARKET TRENDS
11 Dec 2025
Metabolic Breakthroughs Fuel Race for Next Gen TherapiesTECHNOLOGY
10 Dec 2025
AI Heats Up the Search for New Metabolic Treatments
Metabolic Deals Speed a New US Race to Transform Liver Care
PARTNERSHIPS
9 Dec 2025
Novo Nordisk’s move for Akero boosts momentum in metabolic care; industry players should prepare for faster shifts in liver-disease treatment
INVESTMENT
15 Dec 2025
A $70M Bet on Longer-Lasting Metabolic Drugs
Prolynx lands fresh funding and a new CEO as investors shift focus to durability and adherence in next-generation obesity therapies
INNOVATION
12 Dec 2025
FDA Qualifies AI Tool to Support MASH Clinical Trials
FDA qualification of an AI pathology tool could streamline MASH trials by improving consistency, hinting at broader acceptance of AI in dr...
MARKET TRENDS
11 Dec 2025
Metabolic Breakthroughs Fuel Race for Next Gen Therapies
Lilly’s data and Zealand’s Roche pact accelerate a fast-shifting field of metabolic care
TECHNOLOGY
10 Dec 2025
AI Heats Up the Search for New Metabolic Treatments
AI efforts from Insilico, Nabla Bio, and Takeda speed early metabolic drug design and push firms toward faster data focused R and D
PARTNERSHIPS
9 Dec 2025
Metabolic Deals Speed a New US Race to Transform Liver Care
Novo Nordisk’s move for Akero boosts momentum in metabolic care; industry players should prepare for faster shifts in liver-disease treatm...
INSIGHTS
8 Dec 2025
The Oral Bet Challenging Today’s GLP 1 Era
Aardvark and Rivus advance early stage metabolic therapies as interest grows beyond GLP 1 drugs and potential new options emerge
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.